Regulatory News:
BioInvent (STO:BINV):
Fourth quarter and full year report 2013
· Net sales for January – December 2013 amounted to SEK 82 (43) million, whereof the fourth quarter SEK 50 (9,3) million.
Help employers find you! Check out all the jobs and post your resume.
